NMIBC: Clinical Trials

1 trial for NMIBC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow NMIBC: new trials by email Literature Review of NMIBC trials Research Report on NMIBC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
AU-011, AU-011 in Combination with Medical Laser Adminstration, AU-011 in Combination with Medical Laser Administration - Non-muscle-invasive Bladder Cancer, NMIBC
Phase 1Active not recruitingAura Biosciences552022-09-262026-08-06

Narrower conditions

Non-Muscle Invasive Bladder Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Carcinoma (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Sponsors

Aura Biosciences (1)

Countries

Australia (1)  ·  United States (1)